)
Oramed Pharmaceuticals (ORMP) investor relations material
Oramed Pharmaceuticals Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Annual meeting scheduled for September 15, 2026, with voting available online or in person.
Shareholders are encouraged to review proxy materials and vote on key proposals affecting governance and compensation.
Voting matters and shareholder proposals
Election of six directors for a one-year term, with all nominees recommended by the board.
Ratification of Kesselman & Kesselman as independent auditors for the fiscal year ending December 31, 2026.
Approval sought for an amendment to increase shares under the Long-Term Incentive Plan by 3,000,000, totaling 12,500,000 shares.
Advisory vote on executive compensation and on the frequency of future say-on-pay votes.
Proposal to adjourn the meeting if additional time is needed for proxy solicitation.
Board of directors and corporate governance
Six director nominees listed: Nadav Kidron, Dr. Miriam Kidron, Dr. Daniel Aghion, Dr. Arie Mayer, Yehuda Reznick, and Benjamin Shapiro.
Directors to serve for one year or until successors are elected and qualified.
- Board recommends approval of all proposals, including director elections and incentive plan amendment.ORMP
Proxy filing3 Aug 2026 - Net income reached $54M, assets rose 42%, driven by investment gains and strategic activity.ORMP
Q3 202530 Jun 2026 - Net loss of $19.1M in 2024, with a strategic shift to new clinical trials and diversified investments.ORMP
Q4 202430 Jun 2026 - 2025 net income surged to $64M, fueled by investment gains and strategic asset transfers.ORMP
Q4 202530 Jun 2026 - Q1 2025 net loss of $7.6M on $2.0M revenue, JV delayed, and major investments in Scilex and real estate.ORMP
Q1 202530 Jun 2026 - Returned to profitability with $10.7M net income, strong cash, and new buyback and JV initiatives.ORMP
Q2 202430 Jun 2026 - Net income reached $5.6M in H1 2025, with strong financial income and diversified investments.ORMP
Q2 202530 Jun 2026 - Annual meeting to vote on directors, executive pay, and auditor ratification, all board-recommended.ORMP
Proxy filing30 Jun 2026 - Q1 2026 net income surged to $38.3M, fueled by investment gains and the Lifeward transaction.ORMP
Q1 202630 Jun 2026
Next Oramed Pharmaceuticals earnings date
Next Oramed Pharmaceuticals earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)